In contrast, the increase in C-reactive protein observed in patients undergoing to pulmonary embolism suggests the crucial role of inflammation in the pathogenesis of thrombotic complications in patients affected by SARS-CoV 2 infection. The gene discussed is CRP; the disease is pulmonary embolism.